MIR3648-1

Across TCGA pan-cancer cohorts, MIR3648-1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR3648-1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR3648-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3648-1 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

LUAD, STAD, and LGG are the cancer types where MIR3648-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.216	0.835	<.001	54	view →
STAD	OS	Tertile	III,IV	0.707	0.335	.005	24	view →
LGG	DFS	Tertile	All	0.377	0.743	.002	21	view →
SKCM	OS	Tertile	All	0.258	0.781	.020	18	view →
HNSC	OS	Tertile	All	0.407	0.770	.020	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR3648-1–LUAD (OS)

Open the LUAD breakdown →